Data / Drug companies / Valganciclovir
Valganciclovir: 14 companies and 14 products in the FDA NDC directory
Valganciclovir is listed in the FDA National Drug Code Directory by 14 companies, with 14 products in commercial distribution. 13 of the products (92.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; powder, for solution; for solution, and the newest product started marketing on October 28, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 14
- Products
- 14
- Generic (ANDA) products
- 13 (92.9%)
- Application numbers
- 9
- Routes
- Oral
- Brand names
- Valcyte
- openFDA record search
- api.fda.gov
Companies that list valganciclovir
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Airis Pharma PVT LTD | 1 | for solution | Generic drugs (ANDA) | February 28, 2022 |
| Ajanta Pharma USA Inc. | 1 | tablet | Generic drugs (ANDA) | December 26, 2019 |
| Alembic Pharmaceuticals Inc. | 1 | powder, for solution | Generic drugs (ANDA) | October 28, 2026 |
| Alembic Pharmaceuticals Limited | 1 | powder, for solution | Generic drugs (ANDA) | October 28, 2026 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | January 16, 2015 |
| AvPAK | 1 | tablet, film coated | Generic drugs (ANDA) | July 27, 2016 |
| Camber Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | March 18, 2016 |
| Dr. Reddy's Laboratories Limited | 1 | tablet, film coated | Generic drugs (ANDA) | December 15, 2014 |
| Florida Pharmaceutical Products, LLC | 1 | powder, for solution | Generic drugs (ANDA) | July 1, 2023 |
| Granules Pharmaceuticals Inc. | 1 | for solution | Generic drugs (ANDA) | July 1, 2021 |
| H2-Pharma, LLC | 1 | tablet, film coated | New drug applications (NDA) | March 29, 2001 |
| Major Pharmaceuticals | 1 | tablet, film coated | Generic drugs (ANDA) | March 18, 2016 |
| Micro Labs Limited | 1 | powder, for solution | Generic drugs (ANDA) | June 1, 2026 |
| Somerset Therapeutics, LLC | 1 | for solution | Generic drugs (ANDA) | January 15, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 6 | 42.9% |
| Powder, for solution | 4 | 28.6% |
| For solution | 3 | 21.4% |
| Tablet | 1 | 7.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 13 | 92.9% |
| New drug applications (NDA) | 1 | 7.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor | 14 |
| Nucleoside Analog Antiviral | 12 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.